✨
AI Summary
- Affibody CEO discusses antibody mimetics for radioligand therapy.
- Their platform offers antibody selectivity with small molecule flexibility.
- Focus on HER2 imaging and therapeutic programs using Albumod technology.
Guests on This Episode
DB
David Bejker
1 podcast appearance